Humulin 70/30 (insulin human) NDC 0002-8715

NDC codes

FDA NDC Directory

Product NDC (as listed)0002-8715Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00002-8715Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0002-8715-01	00002871501	1 VIAL, MULTI-DOSE in 1 CARTON (0002-8715-01) / 10 mL in 1 VIAL, MULTI-DOSEMarketed from Jun 26, 1989

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Humulin 70/30Suffix: 70/30
Generic name (nonproprietary): insulin human
Active ingredients: Insulin human — 100 [iU]/mL
Dosage form: Injection, Suspension
Route: Subcutaneous
Labeler: Eli Lilly and Company
Product type: Over-the-counter drug
Marketing category: BLA — Biologics License ApplicationApplication BLA 019717
Marketing start: Jun 26, 1989
Listing expires: Dec 31, 2027
Other FDA classes: Insulin (Chemical structure)
Identifiers: Product ID 0002-8715_75e52ccc-04da-4ae9-9a7b-23837ac3156aSPL ID 75e52ccc-04da-4ae9-9a7b-23837ac3156aSPL set ID e245e0c5-b2d6-418b-baa4-1c3324292885RxCUI 106892, 311048, 847187, 847189UNII 1Y17CTI5SR
Pharmacologic class: Insulin

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400002871501 followed by a unit qualifier and the quantity

Package 00002-8715-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 17, 2026.

Indications (excerpt from the label)

HUMULIN 70/30 is a fixed ratio insulin formulation indicated to improve glycemic control in adults with diabetes mellitus. HUMULIN ® 70/30 is a mixture of insulin isophane human, an intermediate-acting human insulin, and insulin human, a short-acting insulin human, indicated to improve glycemic control in adults with diabetes mellitus. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under BLA 019717

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 019717
Product	Strength	Form · route	Labeler	Product NDC
Humulin 70/30 KwikPeninsulin human	Insulin human 100 [iU]/mL	Injection, SuspensionSubcutaneous	Eli Lilly and Company	0002-8803